June 2012 Drug Information Update - Pharmacy Benefits ...
June 2012 Drug Information Update - Pharmacy Benefits ...
June 2012 Drug Information Update - Pharmacy Benefits ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Current <strong>Drug</strong> Shortages<br />
Rifampin for Injection<br />
May 1, <strong>2012</strong><br />
Products Affected - Description<br />
Rifampin for injection, Bedford<br />
600 mg lyophilized vial (NDC 55390-0123-01)<br />
Reason for the Shortage<br />
• Akorn has sold rifampin to Pfizer who took over the product as of May 1, 2011.<br />
• Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011 on a<br />
temporary basis. Product will become available in stages as production resumes.<br />
• Bedford Laboratories has temporarily suspended the distribution of Ben Venue Laboratories<br />
manufactured products. Availability of products is updated on the Bedford Laboratories website.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=350<br />
Source website: www.ashp.org<br />
Potassium Phosphate Injection<br />
May 1, <strong>2012</strong><br />
Products Affected - Description<br />
Potassium phosphate injection, American Regent<br />
3 mMol/mL, 5 mL vial (NDC 00517-2305-25)<br />
3 mMol/mL, 15 mL vial (NDC 00517-2315-25)<br />
Potassium phosphate injection, Hospira<br />
3 mMol/mL, 5 mL vial (NDC 00409-7296-01)<br />
3 mMol/mL, 15 mL vial (NDC 00409-7295-01)<br />
Reason for the Shortage<br />
• Hospira was discontinuing their potassium phosphate injections but will be returning to<br />
market with the 5 mL and 15 mL sizes to help meet demand.<br />
• American Regent had temporarily suspended manufacture of most drug products<br />
including all potassium phosphate presentations in April, 2011.<br />
• American Regent resumed manufacturing in Shirley, New York in early-May, 2011.<br />
• American Regent has issued a statement that all lots of potassium phosphate may contain<br />
glass particles and filters must be used. Do not use if there are visible glass particles and<br />
filter all other product.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=709<br />
Source website: www.ashp.org<br />
Methazolamide Tablets<br />
May 1, <strong>2012</strong><br />
Products Affected - Description<br />
Methazolamide Tablets, Fera<br />
25 mg tablets, 100 count (NDC 48102-0100-01)<br />
50 mg tablets, 100 count (NDC 48102-0101-01)<br />
Methazolamide Tablets, Sandoz<br />
25 mg tablets, 100 count (NDC 00781-1072-01)<br />
50 mg tablets, 100 count (NDC 00781-1071-01)<br />
Reason for the Shortage<br />
32
Change language